Galmed Pharmaceuticals Ltd (GLMD) is near the middle in its sector according to InvestorsObserver.
GLMD gets an overall rating of 17. That means it scores higher than 17% of stocks.
Galmed Pharmaceuticals Ltd gets a 64 rank in the Healthcare sector. Healthcare is number 3 out of 11 sectors.
What do These Ratings Mean?
Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. Investors Observer makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style.
Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Galmed Pharmaceuticals Ltd Stock Today?
Galmed Pharmaceuticals Ltd (GLMD) stock is trading at $3.81 as of 12:15 PM on Wednesday, Mar 3, a decline of -$0.12, or -3.05% from the previous closing price of $3.93. The stock has traded between $3.65 and $3.94 so far today. Volume today is light. So far 198,016 shares have traded compared to average volume of 567,063 shares.
Click Here to get the full Stock Score Report on Galmed Pharmaceuticals Ltd (GLMD) Stock.
